Occasional trader seeking to exchange long ideas, looking for value and momentum plays.

Banking and financial services professional with over 12 years experience. Like to trade and invest, solid companies with potential, undiscovered, undervalued. Looking for the next Apple.

ALL CONTRIBUTIONS

E Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
This cash-generating bio-pharma is heading for a positive trajectory in 2015 and beyond.
Read

Comments

Latest Comments
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
4 years ago

Trevor, please see my reply to Mike Faragut below. In regards to your hypothetical question on rejection, note that the FDA's advisory board recommended approval of the drug back in 2007. The FDA then issued them an "approvable" letter in Aug '08. This is all before the partnership with Merck and the subsequent approval and launch in the EU. See:

www.cardiome.com/.../cardiome-and-astellas-announce-receipt-fda-approvable-letter-kynapid

In this article: CRME, MRK
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
4 years ago

No, I'd say it was firmly down to a lack of intelligence

In this article: CRME, MRK
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
4 years ago

They're concentrating on IV for now as it as approved. Oral is the next step

In this article: CRME, MRK
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
4 years ago

The world outside the US is a big enough market. As stated in the article, the company is expanding in Europe, South America, China.. They don't need the US market to be profitable

In this article: CRME, MRK
Cardiome Pharma: Why This Bio Gem Could Be An Easy Double This Year
4 years ago

I'm guessing lack of server space? It was up until recently, I think they just pull down older stuff no longer getting traffic.

In this article: CRME, MRK
1 to 5 of 5 comments

STOCKS I FOLLOW

AAPL Apple Inc.

TWEETS

PERSONAL BLOG

Latest Posts

Work Experience

Education

Publications